Associate Professor of Epidemiology
Secondary Appointment: Biostatistics
A-530 Crabtree Hall
University of Pittsburgh
Pittsburgh, PA 15261
Voice: 412-624-1618
E-mail: mbrooks@pitt.edu











Research Interests

• Clinical trial design and coordination for cardiology and diabetes interventions.
• Epidemiological research in chronic and infectious diseases.
• Application of survival analysis and longitudinal data analysis techniques to clinical and quality of life data.

Current Research Studies

• The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) NHLBI
• Optimizing Outcome after Pediatric Heart Transplantation: Specialized Centers of Clinically Oriented Research (SCCOR) Biostatistics and Data Management Core NHLBI
• Study of Women's Health Across the Nation (SWAN) NIA
• Center of Excellence in Prevention and Control of Antibiotic Resistant Bacterial Infections, PA DoH

Education & Training

• University of North Carolina, Chapel Hill – Ph.D. Statistics, 1991
• Harvard University - M.A. Statistics, 1986
• Williams College - B.A. cum laude Mathematics, 1985

Selected Publications

The BARI 2D Study Group (corresponding author MMBrooks). A randomized trial of therapies for type 2 diabetes and coronary artery disease. New England Journal of Medicine. 2009; 360:2503-15.

Schneider DJ, Hardison RM, Lopes N, Sobel BE, Brooks MM. Pro-Thrombosis Ancillary Study Group. Association between Increased Platelet P-selectin Expression and Obesity in Patients with Type 2 Diabetes: A BARI 2D Sub-study. Diabetes Care. 2009; 32:944-949.

Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009; 4:373:1190-7.

Girnita DM, Brooks MM, Webber SA, Burckart GJ, Ferrell R, Zdanowicz G, DeCroo S, Smith L, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Ranganathan S, Naftel D, Girnita AL, Zeevi A. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: A multi-institutional study. Transplantation. 2008; 85:1632-9.

DeVita MA, Brooks MM, Zawistowski C, Rudich S, Daly B, Chaitin E. Donors after Cardiac Death: Validation of Identification Criteria (DVIC) study for predictors of rapid death. American Journal of Transplantation. 2008;8:432-41.

Holmes DR, Kim LJ, Brooks MM, Kip KE, Schaff HV, Detre KM, Frye RL. The impact of CABG on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation (BARI). Journal of Thoracic and Cardiovascular Surgery. 2007;134:38-46.

The BARI Investigators (corresponding author MMBrooks). The Final Ten-Year Follow-up Results from the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial. Journal of the American College of Cardiology, 2007:49:1600-6.

Brooks MM, Frye RL, Genuth S, Detre KM, Nesto RW, Sobel BE, Kelsey SF, Orchard TJ. Hypotheses, design and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. American Journal of Cardiology, 2006;97:9G-19G.

Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orzulak TA, Follmann D, Sopko G, Blackstone EH, Califf RM. Predictors of mortality and mortality from cardiac causes in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and registry. Circulation, 2000;101:2682-9.

Detre KM, Lombardero MS, Brooks MM, Hardison RM, Holubkov R, Sopko G, Frye RL, Chaitman. The effect of previous coronary artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. New England Journal of Medicine, 2000;342:989-97.